Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Paclitaxel or its derivatives I DEC / 13
Palbociclib or its salts I AUG / 16
Palifermin I DEC / 13
Paliperidone or its salts or its derivatives I DEC / 13
Palivizumab I DEC / 13
Palonosetron or its salts

including but not limited to palonosetron hydrochloride

I DEC / 13
Pamidronic acid or its salts I DEC / 13
Pancreatic extracts

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
Pancreatin

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
Pancrelipase

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
Pancuronium or its salts I DEC / 13
Panitumumab I DEC / 13
Pantoprazole or its salts I DEC / 13
Papaveretrine or its salts I SEP / 98
Papaverine or its salts I SEP / 98
Paraldehyde I DEC / 13
Paramethadione I DEC / 13
Pargyline or its salts I DEC / 13
Paricalcitol I DEC / 13
Paritaprevir (Veruprevir) I MAR / 15
Paroxetine or its salts I DEC / 13
Paroxypropione II SEP / 98
Pasireotide or its salts I DEC / 13
Patiromer sorbitex calcium I NOV / 18
Patisiran or its salts I JUL / 19
Pazopanib or its salts I DEC / 13
Pegaptanib or its salts I DEC / 13
Pegaspargase I APR / 17
Pegfilgrastim I DEC / 13
Pegvisomant I DEC / 13
Pembrolizumab I JUN / 15
Pemetrexed or its salts I DEC / 13
Pemoline and any salts thereofC4 I JAN / 03
Penciclovir or its salts I DEC / 13
Penicillamine I DEC / 13
Penicillin or its salts or derivatives

Including but not limited to:
Amoxicillin, ampicillin, azlocillin, benzathine penicillin, carbenicillin, cloxacillin, dicloxacillin, hetacillin, mecillinam, methicillin, mezlocillin, nafcillin, oxacillin, ticarcillin, penicillin G (benzyl penicillin), procaine penicillin G.
 

I DEC / 18
Pentaerythritol tetranitrate I SEP / 98
Pentagastrin and its salts II SEP / 98
Pentamidine or its salts I DEC / 13
PentazocineN I JUN / 02
PentobarbitalC1 I JUN / 02
Pentolinium tartrate I DEC / 13
Pentosan polysulfate or its salts I DEC / 13
Pentostatin or its salts I DEC / 13
Pentoxifylline or its salts I DEC / 13
Peramivir or its salts or derivatives I MAR / 17
Perampanel I DEC / 13
Perflutren I DEC / 13
Pergolide or its salts I DEC / 13
Pericyazine or its salts I DEC / 13
Perindopril or its salts I DEC / 13
Permethrin and its derivatives II SEP / 98
Permethrin or its derivatives

For veterinary use, when recommended in cats.

I DEC / 13
Perphenazine or its salts I DEC / 13
Pertussis vaccine II DEC / 98
Pertuzumab I DEC / 13
PethidineN I JUN / 02
Pethidine Intermediate CN I JUN / 02
Phacetoperane or its salts I DEC / 13
Phenacemide I DEC / 13
Phenacetin I DEC / 13
PhenadoxoneN I JUN / 02
Phenaglycodol I DEC / 13
PhenampromideN I JUN / 02
PhenazocineN I JUN / 02
Phenazopyridine or its salts I DEC / 13
PhencyclidineN I JUN / 02
Phendimetrazine and any salt thereofC1 I JUN / 02
Phenelzine or its salts I DEC / 13
Phenformin and its salts I DEC / 13
Pheniprazine or its salts I DEC / 13
Pheniramine U
Phenmetrazine and any salt thereofC1 I JUN / 02
Phenol preparations with concentration of more than 20% II SEP / 98
PhenomorphanN I JUN / 02
PhenoperidineN I JUN / 02
Phenoxybenzamine and its salts II SEP / 98
Phentermine and any salt thereofC2 I JUN / 02
Phenthoxate or its salts I DEC / 13
Phentolamine or its salts I DEC / 13
Phenylbutazone or its salts I DEC / 13
Phenylbutyric acid or its salts or derivatives

Including but not limited to glycerol phenylbutyrate, phenylbutyrate sodium.

I AUG / 16
Phenylephrine and its salts and preparations in nasal preparations in concentrations of 2.5% or less, for pediatric use II SEP / 98
Phenylephrine and its salts and preparations. for oral use, in nasal preparations for adults and in ophthalmic preparations in concentrations of 2.5% or less U
Phenylephrine or its salts

In preparations for parenteral use or ophthalmic use in concentrations greater than 2.5%.

I DEC / 13
Phenylindanedione or its derivatives I DEC / 13
Phenylpropanolamine or its salts or derivatives I DEC / 13
Phenyltoloxamine and its salts III SEP / 98
PholcodineN I JUN / 02
Physostigmine salicylate

For human use - except preparations for oral or topical use only.

I DEC / 13
Physostigmine salicylate.

for oral or topical use

II SEP / 98
Phytocannabinoids produced by, or found in, the cannabis plant and substances that are duplicates of such phytocannabinoids.*

except:
1) derivatives of cannabis as defined in subsection 2(1) of the Cannabis Act that are exempt from the application of the Cannabis Act under the Industrial Hemp Regulations and that do not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid, or

2) anything referred to in Schedule 2 to the Cannabis Act that contains no more than 10 µg/g delta-9-tetrahydrocannabinol and that does not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid.

*Note: this listing is copied from the Health Canada Prescription Drug List and applies to products that have received a Notice of Compliance and Drug Identification Number and been classified as prescription drugs by Health Canada. Cannabis products, as defined in the Cannabis Act and its regulations, are not granted a Notice of Compliance and Drug Identification Number by Health Canada and are considered outside the scope of the National Drug Schedules.

I OCT / 18
Pibrentasvir I SEP / 17
Pilocarpine or its salts I DEC / 13
Pimecrolimus I DEC / 13
PiminodineN I JUN / 02
Pimobendan I DEC / 13
Pimozide I DEC / 13
Pinaverium bromide I DEC / 13
PinazepamTS I JUN / 02

210 result(s)


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act